Literature DB >> 32920623

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).

S Walter1, T B Clanton, O G Langford, M S Rafii, E J Shaffer, J D Grill, G A Jimenez-Maggiora, R A Sperling, J L Cummings, P S Aisen.   

Abstract

BACKGROUND: The Alzheimer Prevention Trials (APT) Webstudy is the first stage in establishing a Trial-ready Cohort for Preclinical and Prodromal Alzheimer's disease (TRC-PAD). This paper describes recruitment approaches for the APT Webstudy.
OBJECTIVES: To remotely enroll a cohort of individuals into a web-based longitudinal observational study. Participants are followed quarterly with brief cognitive and functional assessments, and referred to Sites for in-clinic testing and biomarker confirmation prior to enrolling in the Trial-ready Cohort (TRC).
DESIGN: Participants are referred to the APT Webstudy from existing registries of individuals interested in brain health and Alzheimer's disease research, as well as through central and site recruitment efforts. The study team utilizes Urchin Tracking Modules (UTM) codes to better understand the impact of electronic recruitment methods.
SETTING: A remotely enrolled online study. PARTICIPANTS: Volunteers who are at least 50 years old and interested in Alzheimer's research. MEASUREMENTS: Demographics and recruitment source of participant where measured by UTM.
RESULTS: 30,650 participants consented to the APT Webstudy as of April 2020, with 69.7% resulting from referrals from online registries. Emails sent by the registry to participants were the most effective means of recruitment. Participants are distributed across the US, and the demographics of the APT Webstudy reflect the referral registries, with 73.1% female, 85.0% highly educated, and 92.5% Caucasian.
CONCLUSIONS: We have demonstrated the feasibility of enrolling a remote web-based study utilizing existing registries as a primary referral source. The next priority of the study team is to engage in recruitment initiatives that will improve the diversity of the cohort, towards the goal of clinical trials that better represent the US population.

Entities:  

Keywords:  Alzheimer’s disease; Trial-ready cohort; online registry; preclinical; prevention; remote recruitment; web-based

Year:  2020        PMID: 32920623      PMCID: PMC7842199          DOI: 10.14283/jpad.2020.46

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  23 in total

Review 1.  Testing the right target and right drug at the right stage.

Authors:  Reisa A Sperling; Clifford R Jack; Paul S Aisen
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

2.  A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers.

Authors:  Arash Mohebati; Allison Knutson; Xi Kathy Zhou; Judith J Smith; Powel H Brown; Andrew J Dannenberg; Eva Szabo
Journal:  Contemp Clin Trials       Date:  2012-07-05       Impact factor: 2.226

3.  GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.

Authors:  Jessica B Langbaum; Jason Karlawish; J Scott Roberts; Elisabeth M Wood; Angela Bradbury; Nellie High; Trisha L Walsh; David Gordon; Raj Aggarwal; Peter Davis; Carter Stowell; Lane Trisko; Carolyn M Langlois; Eric M Reiman; Pierre N Tariot
Journal:  Alzheimers Dement       Date:  2019-02-13       Impact factor: 21.566

4.  The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.

Authors:  Keith N Fargo; Maria C Carrillo; Michael W Weiner; William Z Potter; Zaven Khachaturian
Journal:  Alzheimers Dement       Date:  2016-11       Impact factor: 21.566

5.  Healthybrains.org: From Registry to Randomization.

Authors:  K Zhong; J Cummings
Journal:  J Prev Alzheimers Dis       Date:  2016

6.  Chronic obstructive pulmonary disease self-management activation research trial (COPD-SMART): results of recruitment and baseline patient characteristics.

Authors:  Rennie Russo; David Coultas; Jamile Ashmore; Jennifer Peoples; John Sloan; Bradford E Jackson; Minyong Uhm; Karan P Singh; Steven N Blair; Sejong Bae
Journal:  Contemp Clin Trials       Date:  2015-02-03       Impact factor: 2.226

7.  Predicting Recruitment Feasibility for Acute Spinal Cord Injury Clinical Trials in Canada Using National Registry Data.

Authors:  Ginette Thibault-Halman; Carly S Rivers; Christopher S Bailey; Eve C Tsai; Brian Drew; Vanessa K Noonan; Michael G Fehlings; Marcel F Dvorak; Dilinuer Kuerban; Brian K Kwon; Sean D Christie
Journal:  J Neurotrauma       Date:  2016-10-24       Impact factor: 5.269

8.  Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.

Authors:  Alexander Hein; Paul Gass; Christina Barbara Walter; Florin-Andrei Taran; Andreas Hartkopf; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Rachel Wuerstlein; Debra Lounsbury; Michael P Lux; Diana Lüftner; Markus Wallwiener; Volkmar Müller; Erik Belleville; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Thomas Ganslandt; Matthias Ruebner; Matthias W Beckmann; Andreas Schneeweiss; Peter A Fasching; Sara Y Brucker
Journal:  Breast Cancer Res Treat       Date:  2016-06-09       Impact factor: 4.872

9.  Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.

Authors:  Joshua D Grill; Dan Hoang; Daniel L Gillen; Chelsea G Cox; Adrijana Gombosev; Kirsten Klein; Steve O'Leary; Megan Witbracht; Aimee Pierce
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview.

Authors:  P S Aisen; R A Sperling; J Cummings; M C Donohue; O Langford; G A Jimenez-Maggiora; R A Rissman; M S Rafii; S Walter; T Clanton; R Raman
Journal:  J Prev Alzheimers Dis       Date:  2020
View more
  9 in total

1.  Multidomain trials to prevent dementia: addressing methodological challenges.

Authors:  Manuel Montero-Odasso; G Y Zou; Nellie Kamkar; Howard H Feldman; Sylvie Belleville; Howard Chertkow; Haakon B Nygaard; Surim Son; Mark Speechley
Journal:  Alzheimers Res Ther       Date:  2022-07-11       Impact factor: 8.823

2.  Diversifying Recruitment Registries: Considering Neighborhood Health Metrics.

Authors:  J D Grill; A Kind; D Hoang; D L Gillen
Journal:  J Prev Alzheimers Dis       Date:  2022

3.  The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research.

Authors:  Van M Ta Park; Oanh L Meyer; Janice Y Tsoh; Alka M Kanaya; Marian Tzuang; Bora Nam; Quyen Vuong; Joon Bang; Ladson Hinton; Dolores Gallagher-Thompson; Joshua D Grill
Journal:  Alzheimers Dement       Date:  2022-04-14       Impact factor: 16.655

4.  Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.

Authors:  P S Aisen; R J Bateman; M Carrillo; R Doody; K Johnson; J R Sims; R Sperling; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2021

Review 5.  Early-stage Alzheimer disease: getting trial-ready.

Authors:  Paul S Aisen; Gustavo A Jimenez-Maggiora; Michael S Rafii; Sarah Walter; Rema Raman
Journal:  Nat Rev Neurol       Date:  2022-04-04       Impact factor: 44.711

6.  Quantifying Recruitment Source and Participant Communication Preferences for Alzheimer's Disease Prevention Research.

Authors:  D Julbe-Delgado; J L O'Brien; R Abdulkarim; E M Hudak; H Maeda; J D Edwards
Journal:  J Prev Alzheimers Dis       Date:  2021

7.  TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.

Authors:  G A Jimenez-Maggiora; S Bruschi; R Raman; O Langford; M Donohue; M S Rafii; R A Sperling; J L Cummings; P S Aisen
Journal:  J Prev Alzheimers Dis       Date:  2020

8.  The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.

Authors:  S Walter; O G Langford; T B Clanton; G A Jimenez-Maggiora; R Raman; M S Rafii; E J Shaffer; R A Sperling; J L Cummings; P S Aisen
Journal:  J Prev Alzheimers Dis       Date:  2020

9.  The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview.

Authors:  P S Aisen; R A Sperling; J Cummings; M C Donohue; O Langford; G A Jimenez-Maggiora; R A Rissman; M S Rafii; S Walter; T Clanton; R Raman
Journal:  J Prev Alzheimers Dis       Date:  2020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.